Beutler E, Felitti V, Gelbart T, Ho N
The Scripps Research Institute, La Jolla, CA 92037, USA.
Drug Metab Dispos. 2001 Apr;29(4 Pt 2):495-9.
The regulation of total body iron is important to all organisms. In mammals, the iron content of the body is controlled almost entirely through regulation of absorption. The precise mechanism by which iron is absorbed and the manner in which the absorption is regulated is unknown, but a number of different proteins that are involved either in the transport process itself or its regulation have been identified. These include HFE, a class 1 HLA molecule involved in hereditary hemochromatosis, the divalent metal transporter (DMT-1), hephaestin, the transferrin receptor, and mobilferrin. Iron overload occurs in a number of hereditary disorders including atransferrinemia, aceruloplasminemia, X-linked hereditary sideroblastic anemia, thalassemia major, congenital dyserythropoietic anemia, and various red cell enzyme deficiencies. In Europeans, most cases of hereditary hemochromatosis are due to mutations of the HFE gene. There are two major mutations of this gene c.845G-->A (C282Y) and c.187C-->G (H63D). These mutations have extraordinarily high prevalence in northern Europe and approximately five in a thousand Europeans are homozygous for the 845A mutation. The penetrance of even the homozygous state for the 845A mutation is very low and that for the compound heterozygote 845A/187G, which is also associated with hemochromatosis, is even lower. The reason for the markedly variable penetrance that exists in this disorder remains unknown.
全身铁的调节对所有生物体都很重要。在哺乳动物中,身体的铁含量几乎完全通过吸收调节来控制。铁的吸收的确切机制以及吸收的调节方式尚不清楚,但已经鉴定出许多参与运输过程本身或其调节的不同蛋白质。这些包括HFE,一种参与遗传性血色素沉着症的1类HLA分子、二价金属转运蛋白(DMT-1)、血浆铜蓝蛋白、转铁蛋白受体和可动铁蛋白。铁过载发生在多种遗传性疾病中,包括无转铁蛋白血症、无血浆铜蓝蛋白血症、X连锁遗传性铁粒幼细胞贫血、重型地中海贫血、先天性红细胞生成异常性贫血以及各种红细胞酶缺乏症。在欧洲人中,大多数遗传性血色素沉着症病例是由于HFE基因突变。该基因有两个主要突变,即c.845G→A(C282Y)和c.187C→G(H63D)。这些突变在北欧的患病率极高,大约每千名欧洲人中就有五人是845A突变的纯合子。即使是845A突变纯合状态的外显率也很低,而与血色素沉着症相关的复合杂合子845A/187G的外显率更低。这种疾病中外显率明显变化的原因仍然未知。